Newsmeme!
Discover News you didn't know existed
Pharmaceutical and biotechnology major Wockhardt received USFDA approval for marketing and oral suspension of a combination of Amoxycillin and Clavulanate Potassium.
No tags found at this time. Be the first to tag this news item, learn more.
Wockhardt gets USFDA nod for marketing Augmentin - Business Standard
The company?s Chicago-based subsidiary Morton Grove Pharamaceuticals received approval for marketing the suspension containing 250 mg/ 5ml of Amoxycillin and 62.5mg/ 5ml of Clavulanate Potassium, which is used for treating several common infections ...
Wockhardt`s US arm gets USFDA nod for `Augmentin` - MyIris
Pharmaceutical and biotechnology major Wockhardt, announced, on Thursday, December 04 that it`s Chicago- based subsidiary Morton Grove Pharmaceuticals has received an approval from US Food and Drug Administration (USFDA) for marketing an oral ...
None found at this time.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |